<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1988-04-01" modified="2019-07-03" version="112">
<accession>P0C077</accession>
<accession>P07008</accession>
<name>RELE_ECOLI</name>
<protein>
<recommendedName>
<fullName>mRNA interferase toxin RelE</fullName>
<ecNumber>3.1.-.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Endoribonuclease RelE</fullName>
</alternativeName>
<alternativeName>
<fullName>Toxin RelE</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">relE</name>
<name type="ordered locus">b1563</name>
<name type="ordered locus">JW1555</name>
</gene>
<organism>
<name type="scientific">Escherichia coli (strain K12)</name>
<dbReference type="NCBI Taxonomy" id="83333"/>
<lineage>
<taxon>Bacteria</taxon>
<taxon>Proteobacteria</taxon>
<taxon>Gammaproteobacteria</taxon>
<taxon>Enterobacterales</taxon>
<taxon>Enterobacteriaceae</taxon>
<taxon>Escherichia</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1985" name="EMBO J." volume="4" first="1059" last="1066">
<title>Sequence of the relB transcription unit from Escherichia coli and identification of the relB gene.</title>
<authorList>
<person name="Bech F.W."/>
<person name="Joergensen S.T."/>
<person name="Diderichsen B."/>
<person name="Karlstroem O.H."/>
</authorList>
<dbReference type="PubMed" id="2990907"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<strain>K12 / CS520</strain>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1996" name="DNA Res." volume="3" first="363" last="377">
<title>A 570-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 28.0-40.1 min region on the linkage map.</title>
<authorList>
<person name="Aiba H."/>
<person name="Baba T."/>
<person name="Fujita K."/>
<person name="Hayashi K."/>
<person name="Inada T."/>
<person name="Isono K."/>
<person name="Itoh T."/>
<person name="Kasai H."/>
<person name="Kashimoto K."/>
<person name="Kimura S."/>
<person name="Kitakawa M."/>
<person name="Kitagawa M."/>
<person name="Makino K."/>
<person name="Miki T."/>
<person name="Mizobuchi K."/>
<person name="Mori H."/>
<person name="Mori T."/>
<person name="Motomura K."/>
<person name="Nakade S."/>
<person name="Nakamura Y."/>
<person name="Nashimoto H."/>
<person name="Nishio Y."/>
<person name="Oshima T."/>
<person name="Saito N."/>
<person name="Sampei G."/>
<person name="Seki Y."/>
<person name="Sivasundaram S."/>
<person name="Tagami H."/>
<person name="Takeda J."/>
<person name="Takemoto K."/>
<person name="Takeuchi Y."/>
<person name="Wada C."/>
<person name="Yamamoto Y."/>
<person name="Horiuchi T."/>
</authorList>
<dbReference type="PubMed" id="9097039"/>
<dbReference type="DOI" id="10.1093/dnares/3.6.363"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1997" name="Science" volume="277" first="1453" last="1462">
<title>The complete genome sequence of Escherichia coli K-12.</title>
<authorList>
<person name="Blattner F.R."/>
<person name="Plunkett G. III"/>
<person name="Bloch C.A."/>
<person name="Perna N.T."/>
<person name="Burland V."/>
<person name="Riley M."/>
<person name="Collado-Vides J."/>
<person name="Glasner J.D."/>
<person name="Rode C.K."/>
<person name="Mayhew G.F."/>
<person name="Gregor J."/>
<person name="Davis N.W."/>
<person name="Kirkpatrick H.A."/>
<person name="Goeden M.A."/>
<person name="Rose D.J."/>
<person name="Mau B."/>
<person name="Shao Y."/>
</authorList>
<dbReference type="PubMed" id="9278503"/>
<dbReference type="DOI" id="10.1126/science.277.5331.1453"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Mol. Syst. Biol." volume="2" first="E1" last="E5">
<title>Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110.</title>
<authorList>
<person name="Hayashi K."/>
<person name="Morooka N."/>
<person name="Yamamoto Y."/>
<person name="Fujita K."/>
<person name="Isono K."/>
<person name="Choi S."/>
<person name="Ohtsubo E."/>
<person name="Baba T."/>
<person name="Wanner B.L."/>
<person name="Mori H."/>
<person name="Horiuchi T."/>
</authorList>
<dbReference type="PubMed" id="16738553"/>
<dbReference type="DOI" id="10.1038/msb4100049"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<strain>K12 / W3110 / ATCC 27325 / DSM 5911</strain>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="1998" name="Mol. Microbiol." volume="29" first="1065" last="1076">
<title>The Escherichia coli relBE genes belong to a new toxin-antitoxin gene family.</title>
<authorList>
<person name="Gotfredsen M."/>
<person name="Gerdes K."/>
</authorList>
<dbReference type="PubMed" id="9767574"/>
<dbReference type="DOI" id="10.1046/j.1365-2958.1998.00993.x"/>
</citation>
<scope>FUNCTION AS A TOXIN</scope>
<scope>FUNCTION AS A TRANSCRIPTIONAL COREPRESSOR</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="J. Bacteriol." volume="183" first="2700" last="2703">
<title>Purification of the RelB and RelE proteins of Escherichia coli: RelE binds to RelB and to ribosomes.</title>
<authorList>
<person name="Galvani C."/>
<person name="Terry J."/>
<person name="Ishiguro E.E."/>
</authorList>
<dbReference type="PubMed" id="11274135"/>
<dbReference type="DOI" id="10.1128/JB.183.8.2700-2703.2001"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>RIBOSOME-BINDING</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="14328" last="14333">
<title>RelE, a global inhibitor of translation, is activated during nutritional stress.</title>
<authorList>
<person name="Christensen S.K."/>
<person name="Mikkelsen M."/>
<person name="Pedersen K."/>
<person name="Gerdes K."/>
</authorList>
<dbReference type="PubMed" id="11717402"/>
<dbReference type="DOI" id="10.1073/pnas.251327898"/>
</citation>
<scope>FUNCTION AS A TRANSLATION INHIBITOR</scope>
<scope>INDUCTION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Mol. Microbiol." volume="45" first="501" last="510">
<title>Rapid induction and reversal of a bacteriostatic condition by controlled expression of toxins and antitoxins.</title>
<authorList>
<person name="Pedersen K."/>
<person name="Christensen S.K."/>
<person name="Gerdes K."/>
</authorList>
<dbReference type="PubMed" id="12123459"/>
<dbReference type="DOI" id="10.1046/j.1365-2958.2002.03027.x"/>
</citation>
<scope>FUNCTION AS A TOXIN</scope>
<scope>MUTAGENESIS OF ARG-81 AND 90-ALA--LEU-95</scope>
<source>
<strain>K12</strain>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="Cell" volume="112" first="131" last="140">
<title>The bacterial toxin RelE displays codon-specific cleavage of mRNAs in the ribosomal A site.</title>
<authorList>
<person name="Pedersen K."/>
<person name="Zavialov A.V."/>
<person name="Pavlov M.Y."/>
<person name="Elf J."/>
<person name="Gerdes K."/>
<person name="Ehrenberg M."/>
</authorList>
<dbReference type="PubMed" id="12526800"/>
<dbReference type="DOI" id="10.1016/S0092-8674(02)01248-5"/>
</citation>
<scope>FUNCTION AS AN ENDORIBONUCLEASE ON THE RIBOSOME</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="J. Bacteriol." volume="186" first="8172" last="8180">
<title>Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli.</title>
<authorList>
<person name="Keren I."/>
<person name="Shah D."/>
<person name="Spoering A."/>
<person name="Kaldalu N."/>
<person name="Lewis K."/>
</authorList>
<dbReference type="PubMed" id="15576765"/>
<dbReference type="DOI" id="10.1128/JB.186.24.8172-8180.2004"/>
</citation>
<scope>RELATION WITH PERSISTERS</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E6785" last="E6785">
<title>A differential effect of E. coli toxin-antitoxin systems on cell death in liquid media and biofilm formation.</title>
<authorList>
<person name="Kolodkin-Gal I."/>
<person name="Verdiger R."/>
<person name="Shlosberg-Fedida A."/>
<person name="Engelberg-Kulka H."/>
</authorList>
<dbReference type="PubMed" id="19707553"/>
<dbReference type="DOI" id="10.1371/journal.pone.0006785"/>
</citation>
<scope>FUNCTION IN CELL DEATH</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<scope>ANTIBIOTIC RESISTANCE</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2008" name="J. Mol. Biol." volume="380" first="107" last="119">
<title>Structural mechanism of transcriptional autorepression of the Escherichia coli RelB/RelE antitoxin/toxin module.</title>
<authorList>
<person name="Li G.Y."/>
<person name="Zhang Y."/>
<person name="Inouye M."/>
<person name="Ikura M."/>
</authorList>
<dbReference type="PubMed" id="18501926"/>
<dbReference type="DOI" id="10.1016/j.jmb.2008.04.039"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="Mol. Microbiol." volume="69" first="841" last="857">
<title>Messenger RNA interferase RelE controls relBE transcription by conditional cooperativity.</title>
<authorList>
<person name="Overgaard M."/>
<person name="Borch J."/>
<person name="Joergensen M.G."/>
<person name="Gerdes K."/>
</authorList>
<dbReference type="PubMed" id="18532983"/>
<dbReference type="DOI" id="10.1111/j.1365-2958.2008.06313.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INDUCTION</scope>
<source>
<strain>K12</strain>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="J. Mol. Biol." volume="394" first="183" last="196">
<title>RelB and RelE of Escherichia coli form a tight complex that represses transcription via the ribbon-helix-helix motif in RelB.</title>
<authorList>
<person name="Overgaard M."/>
<person name="Borch J."/>
<person name="Gerdes K."/>
</authorList>
<dbReference type="PubMed" id="19747491"/>
<dbReference type="DOI" id="10.1016/j.jmb.2009.09.006"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INDUCTION</scope>
<source>
<strain>K12</strain>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Mol. Cell" volume="36" first="845" last="860">
<title>Hydroxyurea induces hydroxyl radical-mediated cell death in Escherichia coli.</title>
<authorList>
<person name="Davies B.W."/>
<person name="Kohanski M.A."/>
<person name="Simmons L.A."/>
<person name="Winkler J.A."/>
<person name="Collins J.J."/>
<person name="Walker G.C."/>
</authorList>
<dbReference type="PubMed" id="20005847"/>
<dbReference type="DOI" id="10.1016/j.molcel.2009.11.024"/>
</citation>
<scope>FUNCTION</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / MC4100 / ATCC 35695 / DSM 6574</strain>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="14770" last="14778">
<title>Bacterial toxin RelE mediates frequent codon-independent mRNA cleavage from the 5' end of coding regions in vivo.</title>
<authorList>
<person name="Hurley J.M."/>
<person name="Cruz J.W."/>
<person name="Ouyang M."/>
<person name="Woychik N.A."/>
</authorList>
<dbReference type="PubMed" id="21324908"/>
<dbReference type="DOI" id="10.1074/jbc.M110.108969"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBSTRATE SPECIFICITY</scope>
<source>
<strain>K12 / BW25113</strain>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="13206" last="13211">
<title>Bacterial persistence by RNA endonucleases.</title>
<authorList>
<person name="Maisonneuve E."/>
<person name="Shakespeare L.J."/>
<person name="Joergensen M.G."/>
<person name="Gerdes K."/>
</authorList>
<dbReference type="PubMed" id="21788497"/>
<dbReference type="DOI" id="10.1073/pnas.1100186108"/>
</citation>
<scope>FUNCTION IN PERSISTENCE</scope>
<scope>DISRUPTION PHENOTYPE</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2012" name="J. Bacteriol." volume="194" first="1169" last="1176">
<title>RelE-mediated dormancy is enhanced at high cell density in Escherichia coli.</title>
<authorList>
<person name="Tashiro Y."/>
<person name="Kawata K."/>
<person name="Taniuchi A."/>
<person name="Kakinuma K."/>
<person name="May T."/>
<person name="Okabe S."/>
</authorList>
<dbReference type="PubMed" id="22210768"/>
<dbReference type="DOI" id="10.1128/JB.06628-11"/>
</citation>
<scope>FUNCTION IN DORMANCY</scope>
<scope>ANTIBIOTIC RESISTANCE</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="BMC Microbiol." volume="13" first="45" last="45">
<title>Transcriptional cross-activation between toxin-antitoxin systems of Escherichia coli.</title>
<authorList>
<person name="Kasari V."/>
<person name="Mets T."/>
<person name="Tenson T."/>
<person name="Kaldalu N."/>
</authorList>
<dbReference type="PubMed" id="23432955"/>
<dbReference type="DOI" id="10.1186/1471-2180-13-45"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION BY OTHER TA SYSTEMS</scope>
<source>
<strain>K12 / BW25113</strain>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="Biochemistry" volume="52" first="8633" last="8642">
<title>Bacterial toxin RelE: a highly efficient ribonuclease with exquisite substrate specificity using atypical catalytic residues.</title>
<authorList>
<person name="Griffin M.A."/>
<person name="Davis J.H."/>
<person name="Strobel S.A."/>
</authorList>
<dbReference type="PubMed" id="24251350"/>
<dbReference type="DOI" id="10.1021/bi401325c"/>
</citation>
<scope>FUNCTION</scope>
<scope>PROBABLE ACTIVE SITE</scope>
<scope>MUTAGENESIS OF LYS-52; LYS-54; ARG-61; ARG-81 AND TYR-87</scope>
<source>
<strain>K12 / MG1655 / ATCC 47076</strain>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Prog. Mol. Biol. Transl. Sci." volume="85" first="467" last="500">
<title>mRNA interferases, sequence-specific endoribonucleases from the toxin-antitoxin systems.</title>
<authorList>
<person name="Yamaguchi Y."/>
<person name="Inouye M."/>
</authorList>
<dbReference type="PubMed" id="19215780"/>
<dbReference type="DOI" id="10.1016/S0079-6603(08)00812-X"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Cell" volume="139" first="1084" last="1095">
<title>The structural basis for mRNA recognition and cleavage by the ribosome-dependent endonuclease RelE.</title>
<authorList>
<person name="Neubauer C."/>
<person name="Gao Y.G."/>
<person name="Andersen K.R."/>
<person name="Dunham C.M."/>
<person name="Kelley A.C."/>
<person name="Hentschel J."/>
<person name="Gerdes K."/>
<person name="Ramakrishnan V."/>
<person name="Brodersen D.E."/>
</authorList>
<dbReference type="PubMed" id="20005802"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.11.015"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) IN ISOLATION AND BOUND TO RIBOSOMES BEFORE AND AFTER MRNA CLEAVAGE</scope>
<scope>FUNCTION</scope>
<scope>RIBOSOME-BINDING</scope>
<scope>RRNA-BINDING</scope>
<scope>MECHANISM OF RNA CLEAVAGE</scope>
<scope>MUTAGENESIS OF ARG-61; ARG-81 AND TYR-87</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="14628" last="14636">
<title>Inhibitory mechanism of Escherichia coli RelE-RelB toxin-antitoxin module involves a helix displacement near an mRNA interferase active site.</title>
<authorList>
<person name="Li G.Y."/>
<person name="Zhang Y."/>
<person name="Inouye M."/>
<person name="Ikura M."/>
</authorList>
<dbReference type="PubMed" id="19297318"/>
<dbReference type="DOI" id="10.1074/jbc.M809656200"/>
</citation>
<scope>STRUCTURE BY NMR OF MUTANT 81-ARG--ARG-83 IN COMPLEX WITH RELB FRAGMENT</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2012" name="Structure" volume="20" first="1641" last="1648">
<title>The crystal structure of the intact E. coli RelBE toxin-antitoxin complex provides the structural basis for conditional cooperativity.</title>
<authorList>
<person name="Boggild A."/>
<person name="Sofos N."/>
<person name="Andersen K.R."/>
<person name="Feddersen A."/>
<person name="Easter A.D."/>
<person name="Passmore L.A."/>
<person name="Brodersen D.E."/>
</authorList>
<dbReference type="PubMed" id="22981948"/>
<dbReference type="DOI" id="10.1016/j.str.2012.08.017"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) AND X-RAY CRYSTALLOGRAPHY (2.75 ANGSTROMS) IN COMPLEX WITH RELE</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INDUCTION</scope>
</reference>
<comment type="function">
<text evidence="3 4 5 6 7 8 9 12 13 15 16 17 18 20 22">Toxic component of a type II toxin-antitoxin (TA) system (PubMed:9767574). A sequence-specific, ribosome-dependent mRNA endoribonuclease that inhibits translation during amino acid starvation (the stringent response). In vitro acts by cleaving mRNA with high codon specificity in the ribosomal A site between positions 2 and 3. The stop codon UAG is cleaved at a fast rate while UAA and UGA are cleaved with intermediate and slow rates. In vitro mRNA cleavage can also occur in the ribosomal E site after peptide release from peptidyl-tRNA in the P site as well as on free 30S subunits (PubMed:12526800). In vivo cuts frequently in the first 100 codons, most frequently after the second and third base and rarely near the stop codon (PubMed:21324908). Overexpression of RelE results in the inhibition of bacterial growth and a sharp decrease in colony-forming ability which is neutralized by the labile cognate antitoxin RelB. Overexpression also sharply increases persisters (cells that neither grow nor die in the presence of bactericidal agents and are largely responsible for high levels of biofilm tolerance to antimicrobials) (PubMed:15576765). mRNA interferases play a role in bacterial persistence to antibiotics; overexpression of this protein induces persisters resistant to ciprofloxacin and ampicillin (PubMed:21788497). Plays a role in dormancy when expressed in high-density cells in the absence of antitoxin RelB; amino acid starvation and an unidentified extracellular factor promote dormancy, while expression of antitoxin RelB restores cell culturability (PubMed:22210768). Acts with RelB as a corepressor of relBE transcription, considerably increasing the repression of RelB alone. 2 RelB dimers bind to 2 operator sequences; DNA-binding and repression is stronger when complexed with toxin/corepressor RelE by conditional cooperativity (PubMed:9767574, PubMed:19747491, PubMed:18501926, PubMed:22981948).</text>
</comment>
<comment type="function">
<text evidence="11 14">Seems to be a principal mediator of cell death in liquid media (PubMed:19707553). Implicated in hydroxy radical-mediated cell death induced by hydroxyurea treatment (PubMed:20005847).</text>
</comment>
<comment type="function">
<text evidence="19">Cross-talk can occur between different TA systems. Ectopic expression of this toxin induces transcription of 7 tested TA systems (dinJ/yafQ, hicAB, mazEF, mqsRA, prlF(sohA)/yhaV, relBEF and yefM/yoeB) with specific cleavage of the relBEF mRNA produced immediately upstream and within the relB coding sequence. The cleaved mRNA can be translated into RelE, leading to a positive feedback cycle of RelE expression. The relBEF operon is required for transcription of the mazEF TA system operon during amino acid starvation.</text>
</comment>
<comment type="subunit">
<text evidence="3 8 9 10 12 18">Forms an RelB(2)-RelE(2) heterotetramer (PubMed:18501926, PubMed:22981948). Also forms an RelB(2)-RelE heterotrimer (PubMed:18532983, PubMed:19747491). The RelB(2)-RelE complex is probably the one that binds DNA and represses transcription, possibly as 2 heterotrimers, 1 bound to each of 2 operators (PubMed:22981948, PubMed:19747491). RelE occupies the A site of the 70S ribosome, making extensive contacts with the 16S rRNA. Its presence blocks access of tRNAs and translation factors. RelB bound to RelE prevents RelE from entering the ribosomal A site and thus inhibits its endonuclease activity (PubMed:19297318).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-549378"/>
<interactant intactId="EBI-1124503">
<id>P0C079</id>
<label>relB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="induction">
<text evidence="4 8 9 12 18 19 21 22">By amino acid starvation, by glucose starvation and by chloramphenicol; induction is independent of ppGpp. Autorepressed by RelB, RelE acts as a corepressor (PubMed:9767574, PubMed:19747491, PubMed:18501926, PubMed:22981948). Member of the relBEF operon (PubMed:2990907). Operon induced by ectopic expression of toxins HicA, HipA, MazF, MqsR and itself, but not by YafQ (PubMed:23432955).</text>
</comment>
<comment type="disruption phenotype">
<text evidence="4 11 14 16">Cells missing relBE have a higher steady-state level of translation during amino acid starvation than wild-type cells. They survive antibiotic treatment in log phase better than wild-type cells. Cells missing mazE-mazF survive hydroxyurea treatment better than wild-type; further disruption of relE-relB and tonB yields even better survival (PubMed:20005847). mRNA interferases play a role in bacterial persistence to antibiotics; as 10 mRNA interferases are successively deleted reduced levels of persisters are generated (PubMed:21788497).</text>
</comment>
<comment type="miscellaneous">
<text evidence="12">There are estimated to be 550-1100 RelB and 50-100 RelE molecules in rapidly growing cells of MG1655; as they have quite high affinity for each other (dissociation constant of 0.33 nM) there is probably less than 1 free RelE molecule per cell. The RelB(2)-RelE complex has a half-life of over 70 minutes.</text>
</comment>
<comment type="similarity">
<text evidence="23">Belongs to the RelE toxin family.</text>
</comment>
<dbReference type="EC" id="3.1.-.-"/>
<dbReference type="EMBL" id="X02405">
<property type="protein sequence ID" value="CAA26251.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U00096">
<property type="protein sequence ID" value="AAC74636.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP009048">
<property type="protein sequence ID" value="BAA15262.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="PIR" id="B22830">
<property type="entry name" value="QQECR1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_416081.1">
<property type="nucleotide sequence ID" value="NC_000913.3"/>
</dbReference>
<dbReference type="RefSeq" id="WP_000323025.1">
<property type="nucleotide sequence ID" value="NZ_LN832404.1"/>
</dbReference>
<dbReference type="PDB" id="2KC8">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-95"/>
</dbReference>
<dbReference type="PDB" id="2KC9">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-95"/>
</dbReference>
<dbReference type="PDB" id="4FXE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="D/E/F=1-95"/>
</dbReference>
<dbReference type="PDB" id="4FXH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A/B=1-95"/>
</dbReference>
<dbReference type="PDB" id="4FXI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B/C=1-95"/>
</dbReference>
<dbReference type="PDB" id="4V7J">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="Ay/By=1-95"/>
</dbReference>
<dbReference type="PDB" id="4V7K">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="Ay/By=1-95"/>
</dbReference>
<dbReference type="PDBsum" id="2KC8"/>
<dbReference type="PDBsum" id="2KC9"/>
<dbReference type="PDBsum" id="4FXE"/>
<dbReference type="PDBsum" id="4FXH"/>
<dbReference type="PDBsum" id="4FXI"/>
<dbReference type="PDBsum" id="4V7J"/>
<dbReference type="PDBsum" id="4V7K"/>
<dbReference type="SMR" id="P0C077"/>
<dbReference type="BioGrid" id="4260243">
<property type="interactions" value="139"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1081">
<property type="entry name" value="RelBE toxin-antitoxin complex"/>
</dbReference>
<dbReference type="DIP" id="DIP-35978N"/>
<dbReference type="IntAct" id="P0C077">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="STRING" id="511145.b1563"/>
<dbReference type="PaxDb" id="P0C077"/>
<dbReference type="PRIDE" id="P0C077"/>
<dbReference type="EnsemblBacteria" id="AAC74636">
<property type="protein sequence ID" value="AAC74636"/>
<property type="gene ID" value="b1563"/>
</dbReference>
<dbReference type="EnsemblBacteria" id="BAA15262">
<property type="protein sequence ID" value="BAA15262"/>
<property type="gene ID" value="BAA15262"/>
</dbReference>
<dbReference type="GeneID" id="40046113"/>
<dbReference type="GeneID" id="947549"/>
<dbReference type="KEGG" id="ecj:JW1555"/>
<dbReference type="KEGG" id="eco:b1563"/>
<dbReference type="PATRIC" id="fig|1411691.4.peg.699"/>
<dbReference type="EchoBASE" id="EB1121"/>
<dbReference type="EcoGene" id="EG11131">
<property type="gene designation" value="relE"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG4105K4U">
<property type="taxonomic scope" value="Bacteria"/>
</dbReference>
<dbReference type="eggNOG" id="COG2026">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000219994"/>
<dbReference type="InParanoid" id="P0C077"/>
<dbReference type="KO" id="K06218"/>
<dbReference type="BioCyc" id="EcoCyc:EG11131-MONOMER"/>
<dbReference type="BioCyc" id="ECOL316407:JW1555-MONOMER"/>
<dbReference type="BioCyc" id="MetaCyc:EG11131-MONOMER"/>
<dbReference type="EvolutionaryTrace" id="P0C077"/>
<dbReference type="PRO" id="PR:P0C077"/>
<dbReference type="Proteomes" id="UP000000318">
<property type="component" value="Chromosome"/>
</dbReference>
<dbReference type="Proteomes" id="UP000000625">
<property type="component" value="Chromosome"/>
</dbReference>
<dbReference type="CollecTF" id="EXPREG_00000890"/>
<dbReference type="GO" id="GO:0032993">
<property type="term" value="C:protein-DNA complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CollecTF"/>
</dbReference>
<dbReference type="GO" id="GO:0001217">
<property type="term" value="F:DNA-binding transcription repressor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CollecTF"/>
</dbReference>
<dbReference type="GO" id="GO:0004521">
<property type="term" value="F:endoribonuclease activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="GO" id="GO:0043022">
<property type="term" value="F:ribosome binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="GO" id="GO:0019843">
<property type="term" value="F:rRNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0000976">
<property type="term" value="F:transcription regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CollecTF"/>
</dbReference>
<dbReference type="GO" id="GO:0034198">
<property type="term" value="P:cellular response to amino acid starvation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="GO" id="GO:0006402">
<property type="term" value="P:mRNA catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="GO" id="GO:0017148">
<property type="term" value="P:negative regulation of translation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="GO" id="GO:0046677">
<property type="term" value="P:response to antibiotic"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="EcoCyc"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.2310.20">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR007712">
<property type="entry name" value="RelE/ParE_toxin"/>
</dbReference>
<dbReference type="InterPro" id="IPR035093">
<property type="entry name" value="RelE/ParE_toxin_dom_sf"/>
</dbReference>
<dbReference type="Pfam" id="PF05016">
<property type="entry name" value="ParE_toxin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF143011">
<property type="entry name" value="SSF143011"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR02385">
<property type="entry name" value="RelE_StbE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0046">Antibiotic resistance</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0255">Endonuclease</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0540">Nuclease</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0699">rRNA-binding</keyword>
<keyword id="KW-0346">Stress response</keyword>
<keyword id="KW-1277">Toxin-antitoxin system</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<feature type="chain" description="mRNA interferase toxin RelE" id="PRO_0000097245">
<location>
<begin position="1"/>
<end position="95"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="24">
<location>
<position position="52"/>
</location>
</feature>
<feature type="active site" description="Proton donor" evidence="24">
<location>
<position position="81"/>
</location>
</feature>
<feature type="site" description="Transition state stabilizer" evidence="24">
<location>
<position position="54"/>
</location>
</feature>
<feature type="site" description="Transition state stabilizer" evidence="24">
<location>
<position position="61"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces mRNA cleavage rate constant 2100-fold. Reduces mRNA cleavage rate constant 1000000-fold; when associated with F-87." evidence="20">
<original>K</original>
<variation>A</variation>
<location>
<position position="52"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces mRNA cleavage rate constant 2700-fold." evidence="20">
<original>K</original>
<variation>A</variation>
<location>
<position position="54"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces mRNA cleavage rate constant 2700000-fold." evidence="13 20">
<original>R</original>
<variation>A</variation>
<location>
<position position="61"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significant reduction in endonuclease activity, still binds RelB." evidence="10">
<original>RER</original>
<variation>AEA</variation>
<location>
<begin position="81"/>
<end position="83"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces mRNA cleavage rate constant 60000-fold, significantly less translation inhibition which is countered by RelB. Almost complete loss of mRNA cleavage; when associated with F-87." evidence="5 13 20">
<original>R</original>
<variation>A</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces mRNA cleavage rate constant 180000-fold." evidence="13 20">
<original>Y</original>
<variation>A</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces mRNA cleavage rate constant 130-fold. Almost complete loss of mRNA cleavage; when associated with A-81 (Ref.20). Reduces mRNA cleavage rate constant 1000000-fold; when associated with A-52 (Ref.18)." evidence="13 20">
<original>Y</original>
<variation>F</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not inhibit translation." evidence="5">
<original>AVKRIL</original>
<variation>VTVTVT</variation>
<location>
<begin position="90"/>
<end position="95"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="4"/>
<end position="7"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="9"/>
<end position="17"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="20"/>
<end position="35"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="40"/>
<end position="42"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="45"/>
<end position="47"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="50"/>
<end position="54"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="56"/>
<end position="59"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="60"/>
<end position="67"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="68"/>
<end position="70"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="72"/>
<end position="80"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="82"/>
<end position="84"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="85"/>
<end position="94"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4FXH"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4FXI"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11274135"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11717402"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12123459"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12526800"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15576765"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18501926"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18532983"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19297318"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19707553"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19747491"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20005802"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20005847"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21324908"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21788497"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22210768"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22981948"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23432955"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24251350"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2990907"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9767574"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000305"/>
<evidence key="24" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="24251350"/>
</source>
</evidence>
<sequence length="95" mass="11225" checksum="F516B2E7A437CCEC" modified="1988-04-01" version="1">
MAYFLDFDERALKEWRKLGSTVREQLKKKLVEVLESPRIEANKLRGMPDCYKIKLRSSGY
RLVYQVIDEKVVVFVISVGKRERSEVYSEAVKRIL
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>